-
Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
-
'ICU Medical (ICUI) Remains Well Positioned into 2026'; PT Raised to $180 at KeyBanc
-
Needham Reiterates Hold Rating on ICU Medical (ICUI)
-
ICU Medical (ICUI) Tops Q4 EPS by 20c, provides guidance
-
KeyBanc on Medical Technology: 'From Reset to Rebound?'
-
FDA: ICU Medical recalling IV Gravity Burette set due to Burette component missing internal shut-off valve intended to stop fluid flow
-
KeyBanc on ICU Medical (ICUI): 'Incrementally Positive Around Multi-Year Trajectory'
-
ICU Medical (ICUI) PT Raised at Piper Sandler as 'Commercial Momentum Propels Nice Beat and Raise'
-
Needham Reiterates Hold Rating on ICU Medical (ICUI)
-
ICU Medical (ICUI) Tops Q3 EPS by 61c; offers guidance
-
ICU Medical (ICUI) PT Lowered to $173 at KeyBanc
-
ICU Medical (ICUI) PT Raised to $153 at Piper Sandler
-
ICU Medical (ICUI) Tops Q2 EPS by 60c, provides guidance
-
Needham Reiterates Hold Rating on ICU Medical (ICUI)
-
ICU Medical (ICUI) Tops Q1 EPS by 45c
-
ICUI ALERT: Securities Fraud Investigation by Block & Leviton Could Allow ICU Medical Investors to Recover Losses
-
ICU Medical (ICUI) PT Lowered to $191 at KeyBanc
-
Raymond James Upgrades ICU Medical (ICUI) to Strong Buy
-
Needham Reiterates Hold Rating on ICU Medical (ICUI)
-
ICU Medical (ICUI) Tops Q4 EPS by 62c, provides outlook
-
MedTech stocks 2025 preview: Here are KeyBanc's top picks
-
Jefferies Upgrades ICU Medical (ICUI) to Buy
-
KeyBanc on ICU Medical (ICUI): 'Survey suggests potential market share gains for ICUI'
-
ICU Medical (ICUI) Tops Q3 EPS by 34c
-
Why traders should increase exposure to MedTech stocks: KeyBanc
-
ICU Medical (ICUI) PT Raised to $198 at KeyBanc
-
Jefferies Starts ICU Medical (ICUI) at Hold
-
ICU Medical (ICUI) PT Raised to $190 at Raymond James
-
ICU Medical (ICUI) Tops Q2 EPS by 56c, provides guidance
-
Needham Starts ICU Medical (ICUI) at Hold
-
Raymond James Upgrades ICU Medical (ICUI) to Outperform
-
6 MedTech stocks to own - KeyBanc

